home.social

#hematology — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #hematology, aggregated by home.social.

fetched live
  1. Inherited genetic abnormalities in the SLF2 and SMC5 genes have been identified as a previously unrecognized cause of inherited bone marrow failure syndrome (IBMFS) and a driver of predisposition to myelodysplastic syndromes (MDS).
    #MolecularGenetics #Hematology #Oncology #CellBiology #Leukemia #sflorg
    sflorg.com/2026/08/gen08102601

  2. Inherited genetic abnormalities in the SLF2 and SMC5 genes have been identified as a previously unrecognized cause of inherited bone marrow failure syndrome (IBMFS) and a driver of predisposition to myelodysplastic syndromes (MDS).
    #MolecularGenetics #Hematology #Oncology #CellBiology #Leukemia #sflorg
    sflorg.com/2026/08/gen08102601

  3. Inherited genetic abnormalities in the SLF2 and SMC5 genes have been identified as a previously unrecognized cause of inherited bone marrow failure syndrome (IBMFS) and a driver of predisposition to myelodysplastic syndromes (MDS).
    #MolecularGenetics #Hematology #Oncology #CellBiology #Leukemia #sflorg
    sflorg.com/2026/08/gen08102601

  4. Inherited genetic abnormalities in the SLF2 and SMC5 genes have been identified as a previously unrecognized cause of inherited bone marrow failure syndrome (IBMFS) and a driver of predisposition to myelodysplastic syndromes (MDS).
    #MolecularGenetics #Hematology #Oncology #CellBiology #Leukemia #sflorg
    sflorg.com/2026/08/gen08102601

  5. Inherited genetic abnormalities in the SLF2 and SMC5 genes have been identified as a previously unrecognized cause of inherited bone marrow failure syndrome (IBMFS) and a driver of predisposition to myelodysplastic syndromes (MDS).
    #MolecularGenetics #Hematology #Oncology #CellBiology #Leukemia #sflorg
    sflorg.com/2026/08/gen08102601

  6. Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study

    Adult B-ALL exhibits significant …
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #Acutelymphocyticleukaemia #Biomedicine #CancerResearch #Clinicaltrials #general #Health #Hematology #Oncology
    newsbeep.com/us/789712/

  7. Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study

    Adult B-ALL exhibits significant …
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #Acutelymphocyticleukaemia #Biomedicine #CancerResearch #Clinicaltrials #general #Health #Hematology #Oncology
    newsbeep.com/us/789712/

  8. europesays.com/ie/608599/ Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study #AcuteLymphocyticLeukaemia #Biomedicine #CancerResearch #ClinicalTrials #Éire #general #Health #hematology #IE #Ireland #Medication #oncology

  9. europesays.com/uk/1116492/ Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study #AcuteLymphocyticLeukaemia #Biomedicine #CancerResearch #ClinicalTrials #general #Health #hematology #Medication #oncology #UK #UnitedKingdom

  10. Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study

    Adult B-ALL exhibits significant heterogeneity and poor prog…
    #NewsBeep #News #Medication #Acutelymphocyticleukaemia #Biomedicine #CancerResearch #ClinicalTrials #general #Health #Hematology #Oncology #UK #UnitedKingdom
    newsbeep.com/uk/715729/

  11. Hemodialysis patients with blood type A exhibit significantly lower risks of both all-cause and cardiovascular mortality compared to those with other blood types. This finding directly contrasts with the general population, where blood type O is typically associated with the lowest risk of cardiovascular disease.
    #Nephrology #Cardiology #Hematology #Epidemiology #sflorg
    sflorg.com/2026/07/med07212601

  12. Hemodialysis patients with blood type A exhibit significantly lower risks of both all-cause and cardiovascular mortality compared to those with other blood types. This finding directly contrasts with the general population, where blood type O is typically associated with the lowest risk of cardiovascular disease.
    #Nephrology #Cardiology #Hematology #Epidemiology #sflorg
    sflorg.com/2026/07/med07212601

  13. Hemodialysis patients with blood type A exhibit significantly lower risks of both all-cause and cardiovascular mortality compared to those with other blood types. This finding directly contrasts with the general population, where blood type O is typically associated with the lowest risk of cardiovascular disease.
    #Nephrology #Cardiology #Hematology #Epidemiology #sflorg
    sflorg.com/2026/07/med07212601

  14. Hemodialysis patients with blood type A exhibit significantly lower risks of both all-cause and cardiovascular mortality compared to those with other blood types. This finding directly contrasts with the general population, where blood type O is typically associated with the lowest risk of cardiovascular disease.
    #Nephrology #Cardiology #Hematology #Epidemiology #sflorg
    sflorg.com/2026/07/med07212601

  15. Hemodialysis patients with blood type A exhibit significantly lower risks of both all-cause and cardiovascular mortality compared to those with other blood types. This finding directly contrasts with the general population, where blood type O is typically associated with the lowest risk of cardiovascular disease.
    #Nephrology #Cardiology #Hematology #Epidemiology #sflorg
    sflorg.com/2026/07/med07212601

  16. Researchers have successfully generated red blood cell-like cells capable of producing hemoglobin by utilizing canine induced pluripotent stem cells (iPSCs).
    #VeterinaryMedicine #StemCellBiology #Genetics #Hematology #sflorg
    sflorg.com/2026/07/vet07202601

  17. Researchers have successfully generated red blood cell-like cells capable of producing hemoglobin by utilizing canine induced pluripotent stem cells (iPSCs).
    #VeterinaryMedicine #StemCellBiology #Genetics #Hematology #sflorg
    sflorg.com/2026/07/vet07202601

  18. Researchers have successfully generated red blood cell-like cells capable of producing hemoglobin by utilizing canine induced pluripotent stem cells (iPSCs).
    #VeterinaryMedicine #StemCellBiology #Genetics #Hematology #sflorg
    sflorg.com/2026/07/vet07202601

  19. Researchers have successfully generated red blood cell-like cells capable of producing hemoglobin by utilizing canine induced pluripotent stem cells (iPSCs).
    #VeterinaryMedicine #StemCellBiology #Genetics #Hematology #sflorg
    sflorg.com/2026/07/vet07202601

  20. Researchers have successfully generated red blood cell-like cells capable of producing hemoglobin by utilizing canine induced pluripotent stem cells (iPSCs).
    #VeterinaryMedicine #StemCellBiology #Genetics #Hematology #sflorg
    sflorg.com/2026/07/vet07202601

  21. US FDA Approves Sanofi’s Wearable Injector Form of Blood Cancer Drug

    The U.S. Food and Drug Administration has approved a wearable injector formulation of Sanofi’s blood cancer drug Sarclisa,…
    #France #FR #Europe #EU #Sanofi #bloodcancer #cancercareinnovation #FDAapproval #hematology #infusiontimereduction #multiplemyeloma #on-bodyinjector #Oncology #Sarclisa #SarclisaEscena #subcutaneousdelivery #wearableinjector
    europesays.com/france/50500/

  22. Acute myeloid leukemia (AML) is driven not only by gene mutations but also by its epigenome—specifically, the chromatin state that dictates which genes are active. By mapping these accessible genome regions, researchers have established a new framework that classifies AML into sixteen distinct epigenetic subgroups.
    #Oncology #Epigenomics #MolecularBiology #Hematology #sflorg
    sflorg.com/2026/07/ongy0709260

  23. Acute myeloid leukemia (AML) is driven not only by gene mutations but also by its epigenome—specifically, the chromatin state that dictates which genes are active. By mapping these accessible genome regions, researchers have established a new framework that classifies AML into sixteen distinct epigenetic subgroups.
    #Oncology #Epigenomics #MolecularBiology #Hematology #sflorg
    sflorg.com/2026/07/ongy0709260

  24. Acute myeloid leukemia (AML) is driven not only by gene mutations but also by its epigenome—specifically, the chromatin state that dictates which genes are active. By mapping these accessible genome regions, researchers have established a new framework that classifies AML into sixteen distinct epigenetic subgroups.
    #Oncology #Epigenomics #MolecularBiology #Hematology #sflorg
    sflorg.com/2026/07/ongy0709260

  25. Acute myeloid leukemia (AML) is driven not only by gene mutations but also by its epigenome—specifically, the chromatin state that dictates which genes are active. By mapping these accessible genome regions, researchers have established a new framework that classifies AML into sixteen distinct epigenetic subgroups.
    #Oncology #Epigenomics #MolecularBiology #Hematology #sflorg
    sflorg.com/2026/07/ongy0709260

  26. Acute myeloid leukemia (AML) is driven not only by gene mutations but also by its epigenome—specifically, the chromatin state that dictates which genes are active. By mapping these accessible genome regions, researchers have established a new framework that classifies AML into sixteen distinct epigenetic subgroups.
    #Oncology #Epigenomics #MolecularBiology #Hematology #sflorg
    sflorg.com/2026/07/ongy0709260

  27. New Atellica HEMA 580 Analyzer from Siemens Healthineers helps labs deliver fast, consistent results to improve clinical decision-making

    Siemens Healthineers now offers U.S. laboratories a comprehensive hematology solution that brings together automation, middleware, and remote digital…
    #Germany #DE #Europe #EU #Europa #Siemens #automation #Blood #Hematology #Laboratory #Morphology #siemens
    europesays.com/germany/50474/

  28. 2026 EHA | Over 40 Orelabrutinib Studies Presented,

    BEIJING, June 15, 2026 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing…
    #Europe #EU #BeijingInnoCarePharmaTechCo. #biotech #EHA #Hematology #HongKongStockExchange:9969 #Ltd. #Orelabrutinib
    europesays.com/europe/69510/

  29. europesays.com/ch/69491/ Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA #Advances #and #ASCO #at #breast #cancer #data #EHA #hematology #in #Innovation #Leadership #new #Novartis #prostate) #reinforces #RLT #With

  30. Higher ferritin threshold could detect childhood iron deficiency much earlier

    Many cases of iron deficiency in school-aged children could be diagnosed earlier, according to a new study published…
    #NewsBeep #News #Health #Anemia #AU #Australia #Blood #Cell #Children #Fatigue #hematology #Hemoglobin #irondeficiency #Menstruation #Nutrition #Obesity #physicalactivity #protein #RedBloodCells
    newsbeep.com/au/683335/

  31. Intense physical exercise, such as cycling, can rapidly mobilize hematopoietic stem cells into the bloodstream, serving as a potential adjunctive therapy to enhance stem cell donation procedures for conditions like leukemia.
    #Medical #Hematology #CellBiology #Oncology #sflorg
    sflorg.com/2026/05/med05122601

  32. Intense physical exercise, such as cycling, can rapidly mobilize hematopoietic stem cells into the bloodstream, serving as a potential adjunctive therapy to enhance stem cell donation procedures for conditions like leukemia.
    #Medical #Hematology #CellBiology #Oncology #sflorg
    sflorg.com/2026/05/med05122601

  33. Intense physical exercise, such as cycling, can rapidly mobilize hematopoietic stem cells into the bloodstream, serving as a potential adjunctive therapy to enhance stem cell donation procedures for conditions like leukemia.
    #Medical #Hematology #CellBiology #Oncology #sflorg
    sflorg.com/2026/05/med05122601

  34. Intense physical exercise, such as cycling, can rapidly mobilize hematopoietic stem cells into the bloodstream, serving as a potential adjunctive therapy to enhance stem cell donation procedures for conditions like leukemia.
    #Medical #Hematology #CellBiology #Oncology #sflorg
    sflorg.com/2026/05/med05122601

  35. Intense physical exercise, such as cycling, can rapidly mobilize hematopoietic stem cells into the bloodstream, serving as a potential adjunctive therapy to enhance stem cell donation procedures for conditions like leukemia.
    #Medical #Hematology #CellBiology #Oncology #sflorg
    sflorg.com/2026/05/med05122601

  36. 🩸 Leukemia - Apr 2026

    • High CD81 expression linked to AML treatment resistance
    • Pediatric AML outcomes improve with refined risk stratification
    • TCR therapy targeting Cathepsin G shows strong cytotoxicity in AML
    • MYB activity drives enhancer activation in leukemia

    pir.sh/mq2dpKK1l4

    #Leukemia #Hematology #Biology

  37. 🩸 Leukemia - Apr 2026

    • High CD81 expression linked to AML treatment resistance
    • Pediatric AML outcomes improve with refined risk stratification
    • TCR therapy targeting Cathepsin G shows strong cytotoxicity in AML
    • MYB activity drives enhancer activation in leukemia

    pir.sh/mq2dpKK1l4

    #Leukemia #Hematology #Biology

  38. 🩸 Leukemia - Apr 2026

    • High CD81 expression linked to AML treatment resistance
    • Pediatric AML outcomes improve with refined risk stratification
    • TCR therapy targeting Cathepsin G shows strong cytotoxicity in AML
    • MYB activity drives enhancer activation in leukemia

    pir.sh/mq2dpKK1l4

    #Leukemia #Hematology #Biology

  39. 🩸 Leukemia - Apr 2026

    • High CD81 expression linked to AML treatment resistance
    • Pediatric AML outcomes improve with refined risk stratification
    • TCR therapy targeting Cathepsin G shows strong cytotoxicity in AML
    • MYB activity drives enhancer activation in leukemia

    pir.sh/mq2dpKK1l4

    #Leukemia #Hematology #Biology

  40. 🩸 Leukemia - Apr 2026

    • High CD81 expression linked to AML treatment resistance
    • Pediatric AML outcomes improve with refined risk stratification
    • TCR therapy targeting Cathepsin G shows strong cytotoxicity in AML
    • MYB activity drives enhancer activation in leukemia

    pir.sh/mq2dpKK1l4

    #Leukemia #Hematology #Biology

  41. A one-time intravenous infusion of ferric carboxymaltose is a highly effective treatment for iron deficiency anaemia during pregnancy. It rapidly and efficiently restores iron levels compared to traditional daily oral supplements.
    #Obstetrics #Gynaecology #PublicHealth #Hematology #sflorg
    sflorg.com/2026/05/med05042601